Bram Ramjiawan
Fortuna: - $ al 31/07/2026
Fortuna: - $ al 31/07/2026
Bram Ramjiawan is currently an Independent Director at BioMark Diagnostics, Inc. since 2014 and Director-Research Innovation & Regulatory Affairs at St. Boniface General Hospital since 2008.
Formerly, Dr. Ramjiawan was a Professor at the University of Manitoba.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/07/2025 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOMARK DIAGNOSTICS INC. | Director/Miembro de la Junta | 11/09/2014 |
St. Boniface General Hospital
St. Boniface General Hospital Hospital/Nursing ManagementHealth Services Provides general medical and surgical services and other hospital services | Director Técnico/Científico/I+D | 01/01/2008 |
| Empresas | Cargo | Fin |
|---|---|---|
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
BioMark Diagnostics, Inc.
BioMark Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops technologies for the prediction of cancer | Health Services |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Boniface General Hospital
St. Boniface General Hospital Hospital/Nursing ManagementHealth Services Provides general medical and surgical services and other hospital services | Health Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.